Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionSawyer & Company, Inc
Latest Disclosed Ownership15,813 shares
Latest Disclosed Value $ 5,563,804
Sawyer & Company, Inc reports 1.90% decrease in ownership of AMGN / Amgen Inc.

On April 23, 2026 - Sawyer & Company, Inc filed a 13F-HR form disclosing ownership of 15,813 shares of Amgen Inc. (CH:AMGN) valued at $5,563,804 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 16,119 shares of Amgen Inc.. This represents a change in shares of -1.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F AMGEN COM 031162100 15,813 -306 -1.90 5,564 5.46 2.1425
2026-02-02 2025-12-31 13F AMGEN COM 031162100 16,119 -35 -0.22 5,276 131,775.00 1.8669
2025-10-07 2025-09-30 13F AMGEN COM 031162100 16,154 0 0.00 5 0.00 1.7033
2025-07-09 2025-06-30 13F AMGEN COM 031162100 16,154 401 2.55 5 0.00 1.7033
2025-04-22 2025-03-31 13F AMGEN COM 031162100 15,753 -243 -1.52 5 0.00 1.9826
2025-01-14 2024-12-31 13F AMGEN COM 031162100 15,996 57 0.36 4 -20.00 1.5423
2024-10-10 2024-09-30 13F AMGEN COM 031162100 15,939 77 0.49 5 25.00 1.9003
2024-07-31 2024-06-30 13F AMGEN COM 031162100 15,862 9 0.06 5 -99.91 1.9692
2024-04-16 2024-03-31 13F AMGEN COM 031162100 15,853 -29,752 -65.24 4,507 112,575.00 1.8006
2024-01-17 2023-12-31 13F AMGEN COM 031162100 45,605 29,570 184.41 4 0.00 1.9829
2023-10-25 2023-09-30 13F AMGEN COM 031162100 16,035 174 1.10 4 33.33 2.0122
2023-07-13 2023-06-30 13F AMGEN COM 031162100 15,861 142 0.90 4 0.00 1.6095
2023-04-19 2023-03-31 13F AMGEN COM 031162100 15,719 331 2.15 4 -25.00 2.1235
2023-01-11 2022-12-31 13F AMGEN COM 031162100 15,388 -187 -1.20 4 -99.89 1.9896
2022-10-25 2022-09-30 13F AMGEN COM 031162100 15,575 70 0.45 3,511 -6.92 1.9137
2022-07-20 2022-06-30 13F AMGEN COM 031162100 15,505 -700 -4.32 3,772 -3.75 1.9147
2022-04-26 2022-03-31 13F AMGEN COM 031162100 16,205 220 1.38 3,919 8.98 1.7628
2022-01-14 2021-12-31 13F AMGEN COM 031162100 15,985 132 0.83 3,596 6.67 1.5518
2021-11-03 2021-09-30 13F AMGEN COM 031162100 15,853 220 1.41 3,371 -11.55 1.5900
2021-07-29 2021-06-30 13F AMGEN COM 031162100 15,633 345 2.26 3,811 0.18 1.7790
2021-04-22 2021-03-31 13F AMGEN COM 031162100 15,288 295 1.97 3,804 10.36 1.8946
2021-01-26 2020-12-31 13F AMGEN COM 031162100 14,993 -155 -1.02 3,447 -10.47 1.7577
2020-10-20 2020-09-30 13F AMGEN COM 031162100 15,148 545 3.73 3,850 11.79 2.2905
2020-07-31 2020-06-30 13F AMGEN COM 031162100 14,603 2,635 22.02 3,444 41.96 2.1308
2020-05-06 2020-03-31 13F AMGEN COM 031162100 11,968 795 7.12 2,426 -9.91 1.9354
2020-01-13 2019-12-31 13F AMGEN COM 031162100 11,173 771 7.41 2,693 33.78 1.7340
2019-10-17 2019-09-30 13F AMGEN COM 031162100 10,402 -260 -2.44 2,013 2.44 1.4334
2019-07-23 2019-06-30 13F AMGEN COM 031162100 10,662 -360 -3.27 1,965 -6.16 1.3153
2019-05-06 2019-03-31 13F AMGEN COM 031162100 11,022 465 4.40 2,094 1.90 1.3707
2019-01-25 2018-12-31 13F AMGEN COM 031162100 10,557 -315 -2.90 2,055 -8.83 1.5090
2018-10-22 2018-09-30 13F AMGEN COM 031162100 10,872 65 0.60 2,254 12.98 1.3751
2018-07-18 2018-06-30 13F AMGEN COM 031162100 10,807 480 4.65 1,995 13.29 1.3041
2018-04-17 2018-03-31 13F AMGEN COM 031162100 10,327 395 3.98 1,761 1.97 1.1897
2018-01-11 2017-12-31 13F AMGEN COM 031162100 9,932 9,932 1,727 1.1328
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.